Clinical Trial Update: Parotid-sparing IMRT for Nasopharyngeal Cancer

View source ↗

Summary

This update reports on a completed clinical trial evaluating parotid-sparing intensity-modulated radiotherapy (IMRT) with chemotherapy for nasopharyngeal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Nasopharyngeal Cancers, Intensity Modulated Radiotherapy With Chemotherapy | Status: COMPLETED